The initial success of Viagra undeniably reshaped the medication landscape, but investing in companies heavily reliant on generic versions presents a uncertain picture. Although early returns were significant, the cessation of patents and the rise of discounted alternatives have eroded sales. Thus, a thorough evaluation of current income sources an